New Delhi: India’s leading consumer goods company Dabur India has appointed LinTeractive, the digital division from Lowe Lintas + Partners to handle digital duties for its Dabur Healthcare & Foods division. Some of the company’s leading products/platforms that will be handled by LinTeractive include Dabur Honey, Dabur Chyawanprash, Dabur Shilajit, www.liveveda.com and www.daburmediclub.com.
Expressing his views on choosing LinTeractive as the digital AoR for Dabur Healthcare & Foods, Krishan Kumar Chutani, Executive Vice President – Marketing (Healthcare & Foods) said, “Our association with Lowe Lintas + Partners has been a successful one. They’ve understood the core insights integral to our product offerings and have delivered solutions that have made us stand out in the marketplace. As we seek to extend our reach onto the digital platform, it was only apt that we hand over the reins to our trusted partner to bring us the desired results on the medium. We look forward to some forward-thinking solutions from LinTeractive that will help our brands stay ahead of the curve.”
LinTeractive will be offering capabilities including search, social, web|mobile, monitoring, analytics and campaign activation.
Speaking of the appointment, Vikas Mehta, Head of LinTeractive and CMO, Lowe Lintas + Partners said, “Our decade-long association with Dabur has been a mutually rewarding journey for the both of us. We are excited that LinTeractive has been entrusted with the mandate of creating interaction-marketing solutions for the healthcare products and platforms. We are keen on partnering Dabur in building their digital capabilities as we co-create digital success stories for their brands.”
Dabur India Limited is a leading consumer goods company in India and has marked its presence with significant achievements and commands a market leadership status today. Some of its products have gone on to become category leaders in the space that they operate in. Dabur Honey has a market leadership of over 75 per cent in branded honey market while Dabur Chyawanprash is the largest selling Ayurvedic medicine with over 65 per cent market share.